We collected information about Eyegate Pharmaceuticals Inc Hours for you. Follow the liks to find out everything about Eyegate Pharmaceuticals Inc Hours.
EyeGate is Now Kiora Pharmaceuticals; Provides Update on Company’s Sharpened Clinical Development Strategy SALT LAKE CITY, UT, November 8, 2021 – Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), (“Kiora” or the “Company”) is the new name of …
https://www.benzinga.com/general/biotech/21/07/22159642/why-shares-of-eyegate-pharmaceuticals-spiked-after-hours-monday
EyeGate Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing products for treating inflammatory and immune diseases with a …
https://www.barrons.com/market-data/stocks/eyeg/company-people
EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye.
https://www.nasdaq.com/market-activity/stocks/eyeg/pre-market
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET).
https://www.benzinga.com/pressreleases/21/08/g22453701/eyegate-announces-closing-of-10-75-million-registered-direct-offering-priced-at-the-market-under-n
WALTHAM, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or the "Company"), a clinical-stage company developing and …
https://finance.yahoo.com/news/eyegate-pharma-announces-transformative-acquisition-115500488.html
WALTHAM, Mass., Dec. 21, 2020 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”), a clinical stage company focused on …
https://stockhouse.com/news/press-releases/2021/08/10/eyegate-announces-10-75-million-registered-direct-offering-priced-at-the-market
WALTHAM, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or the “Company”), a clinical-stage company developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and certain systemic diseases, today announced that it has entered …
https://www.msn.com/en-us/money/stockdetails/nas-eyeg/fi-a1sj6h
When the bell rang at previous close EyeGate Pharmaceuticals Inc. (EYEG) was up 7.24% investchronicle 9/14/2021 Analysts Provide Insight On The Potential For EyeGate Pharmaceuticals Inc. (EYEG) To ...
https://investorshub.advfn.com/Eyegate-Pharmaceuticals-Inc-EYEG-30079/
Eyegate Pharma (EYEG) Market Cap $13 Million. Cash $6 Million enough untill mid 2020. Price $3.50. Shares Out 3.6 Million. "Announced approval from the FDA to initiate its photorefractive keratectomy (“PRK”) pivotal study on June 3, 2019 and enrollment of the first patient on June 26, 2019. Topline results are expected by year-end 2019 ...
https://finance.yahoo.com/q?s=eyeg&d=t
Find the latest Eyegate Pharmaceuticals, Inc. (EYEG) stock quote, history, news and other vital information to help you with your stock trading and investing.
Searching for Eyegate Pharmaceuticals Inc Hours?
You can just click the links above. The info is collected for you.
